3.6. MAO Inhibition Assay

NC Nafiz Öncü Can
Ulviye Acar Çevik
BS Begüm Nurpelin Sağlık
Yusuf Özkay
request Request a Protocol
ask Ask a question
Favorite

Enzyme activity assays were performed according to the procedure reported by Matsumoto et al. [54] with slight modifications. In order to prevent the destructive effect of light on MAO enzymes, the assays were performed in 96-well black plates. Phosphate buffer solution (0.1 M, pH = 7.4) was used for preparation of stock solutions (5 mg/mL) of both human recombinant MAO-A and MAO-B enzymes. Enzyme stock solutions were further diluted using assay buffer to achieve a final concentration of 0.006 mg/mL for MAO-A and 0.015 mg/mL for MAO-B. Kynuramine was dissolved in sterile deionized water to prepare stock solution (25 mM) and then diluted using assay buffer to get final concentration of 40 μM for MAO-A enzyme and 20 μM for MAO-B enzyme. Synthesized compounds and reference drugs, which were moclobemide for MAO-A and selegiline for MAO-B, were diluted to 10−3 M and 10−4 M concentrations (100 μL/well) using 2% DMSO. The addition of the test compound solution was followed by addition of either MAO-A or MAO-B enzyme (50 μL/well) solutions. After 10 min of incubation at 37 °C, kynuramine (50 μL/well) was added and enzyme-substrate reaction was initiated. The plate was incubated for 20 min at 37 °C and then reaction was terminated by addition of 2 N NaOH (75 μL/well). The fluorimetric reads from the top was performed at 310 nm excitation and 380 nm emission wavelengths.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A